Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill tested for severe eczema relief

NCT ID NCT06996912

Summary

This study is testing whether an experimental tablet called HSK44459 can improve skin symptoms and reduce itching in adults with moderate-to-severe atopic dermatitis (eczema). Researchers will compare two different doses of the pill against a placebo (inactive pill) over 12 weeks in 150 participants. The main goal is to see how much the treatment reduces the severity of eczema and improves quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Affiliated Dermatology Hospital of Shandong First Medical University

    Jinan, Shandong, 250022, China

Conditions

Explore the condition pages connected to this study.